Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 12, 596 (2006)
Published online: 1 June 2006 | doi:10.1038/nm0606-596a
US court rules to allow experimental drugs for dying patients
Emily Waltz1
- New York
Abstract
The ruling could have dire consequences for drug development.
People dying from a terminal illness have the right to buy experimental drugs from companies before the US Food and Drug Administration (FDA) has approved them, a US federal appeals court ruled in May.If upheld, the ruling could bring hope to people desperately trying to extend their lives, but it could also shake up the government's drug approval process, legal experts say.
To read this story in full you will need to login or make a payment (see right).
